FilingIndex
← The Wire
AURANasdaq

Aura Biosciences, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1501796

Develops precision immunotherapies for solid tumors, aiming to preserve organ function

red 8-K · 90d
$663M
Market cap
$6.88
Last close
-1.7%
1D
-1.0%
5D
383K
Volume
Price · last 39 sessions-17.6%
May 4L $6.12 · H $8.90Jun 29
104
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Feb 17, 2026: 5 sold $619K.

DateInsiderActionSharesPriceValue
Feb 17, 2026De Los Pinos ElisabetSee RemarksSell47,648$5.06$241K
Feb 17, 2026Hopkins Janet JillChief Medical OfficerSell20,401$5.06$103K
Feb 17, 2026Plavsic MarkChief Technology OfficerSell15,890$5.05$80K
Feb 17, 2026Kilroy ConorSee RemarksSell12,079$5.05$61K
Feb 17, 2026Elazzouzi AmySenior Vice President, FinanceSell8,549$5.06$43K
Jan 20, 2026De Los Pinos ElisabetSee RemarksSell16,928$4.86$82K
Jan 20, 2026Elazzouzi AmySenior Vice President, FinanceSell1,581$4.86$8K
Nov 17, 2025Hopkins Janet JillChief Medical OfficerSell17,109$5.42$93K
Oct 29, 2025De Los Pinos ElisabetSee RemarksSell9,049$6.35$57K
Oct 29, 2025Elazzouzi AmySenior Vice President, FinanceSell896$6.35$6K
Oct 16, 2025Plavsic MarkChief Technology OfficerSell12,169$6.35$77K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance